Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial

Auteurs

H.S. Rugo, V. Diéras, K.A. Gelmon, R.S. Finn, D.J. Slamon, M. Martin, P. Neven, Y. Shparyk, A. Mori, D.R. Lu, H. Bhattacharyya, C.H.u.a.n.g. Bartlett, S. Iyer, S. Johnston, J. Ettl, N. Harbeck